Revolutionizing dialysis to save lives from overdoses and liver failures
The team around Dr. Vincent Forster from the ETH spin-off Versantis wins VENTURE KICK 2014
The team around Dr. Vincent Forster from the ETH spin-off Versantis is developing a ground-breaking dialysis approach to remove these toxins from your organism. Versantis uses small hollow spheres (i.e. liposomes) to efficiently and rapidly extract the toxic compounds from the blood. Thanks to its technical simplicity, this new dialysis approach presents a great opportunity to save patients’ lives, even in developing countries, where expensive detoxification therapies are rarely available. Dr. Vincent Forster expressed his enthusiasm about the program: “VENTURE KICK has been extremely kind at opening its large network within the biotech and pharma ecosystem. This bridge towards Switzerland-based advisors and investors is the most valuable support Versantis could profit from at a startup phase. In addition, the business acceleration programs, the online visibility, and obviously, the financial supports were very helpful.”